Additionally, bilirubin can inhibit inflammatory responses by suppressing the release of various inflammatory mediators (e.g., TNF-α, IL-6), thus reducing inflammation-induced damage to vascular endothelial cells and preventing atherosclerosis and other cardiovascular diseases. Here, IL6 is linked to atherosclerosis.